Web Results

Pergolide - Wikipedia


Pergolide (trade names Permax, Prascend) is an ergoline-based dopamine receptor agonist used in some countries for the treatment of Parkinson's disease.

Pergolide - Equine Cushings & Insulin Resistance Group


Pergolide (pergolide mesylate) controls the output of a hormone called ACTH. ... [ ii] [iii] Once a horse is diagnosed with PPID, he will be on pergolide for the rest ...

Pergolide - FDA prescribing information, side effects and uses


Pergolide official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.

Prascend® | Boehringer Ingelheim Vetmedica


Prascend® (pergolide mesylate) is the only FDA-approved formulation of pergolide mesylate on the market approved for use in horses. PRASCEND is the first ...

Pergolide - American Academy of Veterinary Pharmacology and ...


(treatment)EL—Pergolide is used in the treatment of pituitary pars intermedia dysfunction (PPID; equine. Cushing's disease) (Evidence rating: B-3).{R-1-6; 33; 35}.

Pergolide for Horses - Veterinary Pharmacy, Wedgewood Pet RX


General Drug Information and Indications for Pergolide for Horses from Wedgewood Pharmacy.

Pergolide for Veterinary Use


A professional monograph about Pergolide for Veterinary Use by Barbara Forney , VMD.

pergolide | C19H26N2S - PubChem


Pergolide is an oral dopamine receptor agonist used predominantly in the therapy of Parkinson disease. Pergolide therapy is associated with low rate of ...

Pergolide - DrugBank


Jun 13, 2005 ... It was later found that pergolide increased the risk of cardiac valvulopathy. The drug was withdrawn from the US market in March 2007 and from ...

Permax (Pergolide Mesylate): Side Effects, Interactions, Warning ...


Learn about Permax (Pergolide Mesylate) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.